BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Letoha T, Somlai C, Takács T, Szabolcs A, Jármay K, Jr ZR, Hegyi P, Varga I, Kaszaki J, Krizbai I, Boros I, Duda E, Kusz E, Penke B. A nuclear import inhibitory peptide ameliorates the severity of cholecystokinin-induced acute pancreatitis. World J Gastroenterol 2005; 11(7): 990-999 [PMID: 15742402 DOI: 10.3748/wjg.v11.i7.990]
URL: https://www.wjgnet.com/1007-9327/full/v11/i7/990.htm
Number Citing Articles
1
Tamás Letoha, Csaba Somlai, Tamás Takács, Annamária Szabolcs, Zoltán Rakonczay, Katalin Jármay, Tamás Szalontai, Ilona Varga, József Kaszaki, Imre Boros, Ernő Duda, László Hackler, István Kurucz, Botond Penke. The proteasome inhibitor MG132 protects against acute pancreatitisFree Radical Biology and Medicine 2005; 39(9): 1142 doi: 10.1016/j.freeradbiomed.2005.06.003
2
Tamás Letoha, Erzsébet Kusz, Gábor Pápai, Annamária Szabolcs, József Kaszaki, Ilona Varga, Tamás Takács, Botond Penke, Ernő Duda. In Vitro and in Vivo Nuclear Factor-κB Inhibitory Effects of the Cell-Penetrating Penetratin PeptideMolecular Pharmacology 2006; 69(6): 2027 doi: 10.1124/mol.105.019653
3
Arwyn T. Jones, Edward J. Sayers. Cell entry of cell penetrating peptides: tales of tails wagging dogsJournal of Controlled Release 2012; 161(2): 582 doi: 10.1016/j.jconrel.2012.04.003
4
Gene L Bidwell, Drazen Raucher. Therapeutic peptides for cancer therapy. Part I – peptide inhibitors of signal transduction cascadesExpert Opinion on Drug Delivery 2009; 6(10): 1033 doi: 10.1517/17425240903143745
5
Siu Wai Tsang, Yi-Fu Guan, Juan Wang, Zhao-Xiang Bian, Hong-Jie Zhang. Inhibition of pancreatic oxidative damage by stilbene derivative dihydro-resveratrol: implication for treatment of acute pancreatitisScientific Reports 2016; 6(1) doi: 10.1038/srep22859
6
Zheng-hong QIN, Lu-yang TAO, Xin CHEN. Dual roles of NF-κB in cell survival and implications of NF-κB inhibitors in neuroprotective therapyActa Pharmacologica Sinica 2007; 28(12): 1859 doi: 10.1111/j.1745-7254.2007.00741.x
7
Dalia Haydar, Theodore J. Cory, Susan E. Birket, Brian S. Murphy, Keith R. Pennypacker, Anthony P. Sinai, David J. Feola. Azithromycin Polarizes Macrophages to an M2 Phenotype via Inhibition of the STAT1 and NF-κB Signaling PathwaysThe Journal of Immunology 2019; 203(4): 1021 doi: 10.4049/jimmunol.1801228
8
Thomas D. Gilmore, Michael R. Garbati. NF-kB in Health and DiseaseCurrent Topics in Microbiology and Immunology 2010; 349: 245 doi: 10.1007/82_2010_105
9
Yilin Wang, Weiyan Liu, Xiqiang Liu, Meng Sheng, Yaofei Pei, Ruoqing Lei, Shengdao Zhang, Ran Tao. Role of Liver in Modulating the Release of Inflammatory Cytokines Involved in Lung and Multiple Organ Dysfunction in Severe Acute PancreatitisCell Biochemistry and Biophysics 2015; 71(2): 765 doi: 10.1007/s12013-014-0261-5
10
J.K. Durand, A.S. Baldwin. Chromatin Proteins and Transcription Factors as Therapeutic TargetsAdvances in Protein Chemistry and Structural Biology 2017; 107: 77 doi: 10.1016/bs.apcsb.2016.11.006
11
Annamária Szabolcs, Ilona S. Varga, Csaba Varga, Anikó Berkó, József Kaszaki, Tamás Letoha, László Tiszlavicz, Réka Sári, János Lonovics, Tamás Takács. Beneficial effect of resveratrol on cholecystokinin-induced experimental pancreatitisEuropean Journal of Pharmacology 2006; 532(1-2): 187 doi: 10.1016/j.ejphar.2006.01.055
12
Hong Yi, Rui Peng, Lu-yu Zhang, Yan Sun, Hui-min Peng, Han-deng Liu, Li-juan Yu, Ai-ling Li, Ya-juan Zhang, Wen-hao Jiang, Zheng Zhang. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathyCell Death & Disease 2017; 8(2): e2583 doi: 10.1038/cddis.2016.451
13
Annamária Szabolcs, György Biczó, Zoltán Rakonczay, László Tiszlavicz, Gabriella Halm, Tibor Wittmann, Tamás Takács. Simultaneous proteosome inhibition and heat shock protein induction by bortezomib is beneficial in experimental pancreatitisEuropean Journal of Pharmacology 2009; 616(1-3): 270 doi: 10.1016/j.ejphar.2009.05.019
14
Annamária Szabolcs, László Tiszlavicz, József Kaszaki, Anikó Pósa, Anikó Berkó, Ilona S. Varga, Imre Boros, Viktória Szüts, János Lonovics, Tamás Takács. Zerumbone Exerts a Beneficial Effect on Inflammatory Parameters of Cholecystokinin Octapeptide-Induced Experimental Pancreatitis but Fails to Improve HistologyPancreas 2007; 35(3): 249 doi: 10.1097/mpa.0b013e318070d791
15
Amy Aylsworth, Susan X. Jiang, Angele Desbois, Sheng T. Hou. Characterization of the role of full-length CRMP3 and its calpain-cleaved product in inhibiting microtubule polymerization and neurite outgrowthExperimental Cell Research 2009; 315(16): 2856 doi: 10.1016/j.yexcr.2009.06.014
16
Subash C. Gupta, Chitra Sundaram, Simone Reuter, Bharat B. Aggarwal. Inhibiting NF-κB activation by small molecules as a therapeutic strategyBiochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2010; 1799(10-12): 775 doi: 10.1016/j.bbagrm.2010.05.004
17
Sateesh Kumar Arepalli, Minho Choi, Jae-Kyung Jung, Heesoon Lee. Novel NF-κB inhibitors: a patent review (2011 – 2014)Expert Opinion on Therapeutic Patents 2015; 25(3): 319 doi: 10.1517/13543776.2014.998199
18
Beñat Mallavia, Carlota Recio, Ainhoa Oguiza, Guadalupe Ortiz-Muñoz, Iolanda Lazaro, Virginia Lopez-Parra, Oscar Lopez-Franco, Susann Schindler, Reinhard Depping, Jesus Egido, Carmen Gomez-Guerrero. Peptide Inhibitor of NF-κB Translocation Ameliorates Experimental AtherosclerosisThe American Journal of Pathology 2013; 182(5): 1910 doi: 10.1016/j.ajpath.2013.01.022
19
Afaf El-Ansary, Ramesa Shafi Bhat, Sooad Al-Daihan, Abeer M Al Dbass. The neurotoxic effects of ampicillin-associated gut bacterial imbalances compared to those of orally administered propionic acid in the etiology of persistent autistic features in rat pups: effects of various dietary regimensGut Pathogens 2015; 7(1) doi: 10.1186/s13099-015-0054-4
20
Jack R Rivers, Alireza Badiei, Madhav Bhatia. Hydrogen sulfide as a therapeutic target for inflammationExpert Opinion on Therapeutic Targets 2012; 16(5): 439 doi: 10.1517/14728222.2012.673591
21
T.-h. Lin, J. Pajarinen, L. Lu, A. Nabeshima, L.A. Cordova, Z. Yao, S.B. Goodman. Chromatin Proteins and Transcription Factors as Therapeutic TargetsAdvances in Protein Chemistry and Structural Biology 2017; 107: 117 doi: 10.1016/bs.apcsb.2016.11.002